Liposomal Nattokinase
Also known as: Nattokinase, NK
Overview
Nattokinase is a serine protease enzyme derived from *Bacillus subtilis* var. *natto*, a bacterium used in the fermentation of soybeans to produce natto. It is primarily recognized for its potent fibrinolytic activity, meaning it can dissolve fibrin, a key component of blood clots. As a dietary supplement, nattokinase is primarily utilized to support cardiovascular health, with a particular focus on its potential to reduce blood pressure and enhance blood circulation. Research into nattokinase's effects is ongoing, with several studies highlighting its cardiovascular benefits. While systematic reviews and meta-analyses exist, more comprehensive research is needed to fully elucidate its mechanisms and effects. Liposomal formulations of nattokinase are designed to improve its bioavailability by protecting the enzyme from degradation in the gastrointestinal tract, thereby enhancing its absorption and efficacy.
Benefits
Nattokinase has demonstrated significant benefits primarily in cardiovascular health. Its most notable effect is a statistically significant reduction in blood pressure. Meta-analyses have shown that nattokinase supplementation can reduce systolic blood pressure by an average of 3.45 mmHg and diastolic blood pressure by 2.32 mmHg, which is considered clinically significant for individuals with hypertension. This benefit has been observed in studies ranging from weeks to months. The evidence for its effects on blood lipids is mixed; some studies suggest a potential increase in total cholesterol, though this finding is not consistent across all research and may be dosage-dependent. Nattokinase's ability to dissolve fibrin contributes to improved blood circulation. While beneficial for hypertensive individuals, more research is needed to confirm its broader cardiovascular applications and to clarify its impact on cholesterol levels.
How it works
Nattokinase primarily functions as a potent fibrinolytic enzyme, meaning it directly dissolves fibrin, a protein essential for blood clot formation. By breaking down fibrin, nattokinase helps to reduce blood viscosity and improve overall blood circulation. This action contributes to its observed effects on blood pressure reduction and cardiovascular health. It interacts directly with the cardiovascular system by modulating blood clotting processes and enhancing vascular function. The primary molecular target of nattokinase is fibrin. Liposomal formulations are designed to protect the enzyme from degradation by stomach acids and digestive enzymes, thereby enhancing its absorption and bioavailability in the bloodstream, allowing it to exert its systemic effects more effectively.
Side effects
Nattokinase is generally considered safe, with most studies reporting no significant adverse events. Consistent common side effects have not been documented. Some individuals may experience mild gastrointestinal disturbances, though these are not frequently reported. Rare side effects are not well-documented due to limited extensive research. A critical safety consideration is its potent fibrinolytic activity, which necessitates caution when used concurrently with anticoagulant medications (blood thinners) such as warfarin, heparin, or direct oral anticoagulants, as this combination could increase the risk of bleeding. Individuals with pre-existing bleeding disorders, a history of hemorrhagic stroke, or those undergoing surgery should avoid nattokinase. Pregnant or breastfeeding women should consult a healthcare provider before using nattokinase due to insufficient safety data in these populations. It is not a substitute for prescribed medical treatments for cardiovascular conditions.
Dosage
The optimal dosage for nattokinase is not yet definitively established, as studies have utilized varying amounts. However, typical daily dosages range from 100 to 200 mg. There is no clear consensus on a minimum effective dose or a maximum safe dose, and further research is needed to define these parameters precisely. There are no specific timing recommendations for taking nattokinase; it can be taken at any time of day. Liposomal formulations are recommended as they are designed to enhance the absorption and bioavailability of the enzyme by protecting it from degradation in the gastrointestinal tract. No specific cofactors are documented as being required for nattokinase's efficacy. It is important to adhere to product-specific dosing guidelines and consult a healthcare professional, especially when considering higher doses or if you have underlying health conditions.
FAQs
Can I take nattokinase with blood thinners?
No, caution is advised. Nattokinase has fibrinolytic activity, which can increase the risk of bleeding when combined with anticoagulant medications. Always consult your doctor before combining them.
What are the main benefits of nattokinase?
The primary benefit is its potential to reduce blood pressure and improve blood circulation by dissolving fibrin. Some studies also explore its effects on cardiovascular health.
Are there any common side effects?
Nattokinase is generally well-tolerated, with no consistently reported common side effects. Some individuals might experience mild gastrointestinal upset, but this is rare.
How long does it take to see results?
Benefits on blood pressure have been observed in studies lasting from several weeks to a few months. Individual results may vary depending on dosage and health status.
Is liposomal nattokinase better?
Liposomal formulations are designed to enhance nattokinase's bioavailability by protecting it from stomach acid degradation, potentially leading to better absorption and efficacy compared to non-liposomal forms.
Research Sources
- https://pubmed.ncbi.nlm.nih.gov/39076715/ – This systematic review and meta-analysis, involving 546 participants across six studies, found that nattokinase significantly reduces both systolic and diastolic blood pressure. However, it also noted a potential increase in total cholesterol. The study highlighted the high methodological quality of the included research but acknowledged heterogeneity in dosing and study duration.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11266782/ – This meta-analysis, encompassing 399 participants from four studies, investigated the effects of nattokinase on total cholesterol. It concluded that nattokinase supplementation affects total cholesterol differently based on dosage, noting high heterogeneity among the studies. The research pointed out variability in study design and dosing as limitations.
- https://www.mdpi.com/2304-8158/11/13/1867 – This review provides an overview of recent advances in nattokinase research, focusing on its production and various applications, including its potential in fermented soybean foods. While it discusses the enzyme's properties, it primarily covers its broader research landscape rather than specific clinical outcomes or detailed mechanisms of action.

